Company: BSTZ
Filing Date: 2025-04-17
Form Type: SC TO-I
Source: 0001193125-25-084387
Chunk: 1

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-04-17
Form: SC TO-I
Chunk 1
---
 of the regular trading session of the New York Stock Exchange (the “NYSE”), the principal market on which the Shares are traded, on the next day the NAV is calculated after the offer expires (the “Pricing Date”), upon the terms and subject to the conditions set forth in the Offer to Purchase, dated April 17, 2025 (the “Offer to Purchase”), and in the related Letter of Transmittal which are filed as Exhibits (a)(1)(i) and (a)(1)(ii), respectively, to this Schedule TO. This Issuer Tender Offer Statement on Schedule TO is being filed in satisfaction of the reporting requirements of Rule 13e-4(c)(2)promulgated under the Securities Exchange Act of 1934, as amended. The information set forth in the Offer to Purchase and the related Letter of Transmittal is incorporated herein by reference in answer to Item 1 through Item 9 and Item 11 of Schedule TO.

| Item 1. | Summary Term Sheet |

The information set forth under “Summary Term Sheet” in the Offer to Purchase is incorporated herein by reference.

| Item 2. | Subject Company Information |

(a) The name of the issuer is BlackRock Science and Technology Term Trust, a diversified closed-endmanagement investment company organized as a Delaware statutory trust (the “Fund”). The principal executive offices of the Fund are located at 100 Bellevue Parkway, Wilmington, Delaware 19809. The telephone number of the Fund is (800) 882-0052. (b) The title of the securities being sought is common shares of beneficial interest, par value $0.001 per share. As of April 10, 2025, there were 70,506,820 Shares issued and outstanding. (c) The principal market in which the Shares are traded is the NYSE. For information on the high and low sales prices for the Shares in the principal market for each quarter during the past two years, see Section 10, “Price Range of Shares” of the Offer to Purchase, which is incorporated herein by reference.

| Item 3. | Identity and Background of Filing Person |

(a) The Fund is the filing person. BlackRock Advisors, LLC acts as the investment adviser for the Fund (the “Investment Advisor”). The Investment Advisor, located at 100 Bellevue Parkway, Wilmington, Delaware 19809, is a wholly owned subsidiary of BlackRock, Inc. The members of the Fund’s Board of Trustees